Results 121 to 130 of about 116,918 (306)

Has Inequity Faced by Young Australians With Disability Changed Since the Turn of the Century?

Australian Journal of Social Issues, EarlyView.
ABSTRACT Despite the introduction of various policies aimed at promoting equality for people with disability since Australia ratified the Convention on the Rights of People with Disabilities (CRPD) in 2008, there has been little evaluation regarding the extent of change in inequity since then.
Asha Parkinson, Joanne Arciuli, Eric Emerson, Sally Robinson, Sally Chance, Gerry Redmond   +5 more
wiley   +1 more source

Identification and validation of fecal complement component 3 and fibronectin as potential biomarkers for monitoring disease activity in ulcerative colitis based on a mouse model

Animal Models and Experimental Medicine, EarlyView.
This study demonstrated elevated levels of fecal component 3 (C3) and fibronectin (FN) in an ulcerative colitis (UC) mouse model. Importantly, fecal C3 exhibited a stronger correlation with disease activity than the clinically used fecal calprotectin (FC).
Yangyun Guo, Ziheng Yan, Jingyu Ye, Ruifu Yang, Yajun Song, Hui Yue, Yong Zhao   +6 more
wiley   +1 more source

Dextran sulfate enhances the level of an oxidative DNA damage biomarker, 8-oxo-7,8-dihydro-2 0-deoxyguanosine, in rat colonic mucosa [PDF]

, 1998
Dextran sodium sulfate (DSS) given in drinking water can induce colonic Inflammation and produce colorectal tumors in rodents, although it is not directly genotoxic.
Petit, Claude, Embvani, E., Jaeg, Jean-Philippe, Tardieu, Didier, Corpet, Denis E., Cadet, Jean   +5 more
core  

Lactobacillus fermentum BR11, a potential new probiotic, alleviates symptoms of colitis induced by dextran sulfate sodium (DSS) in rats

, 2007
Current treatments for inflammatory bowel disease (IBD) are relatively ineffective. Recently, probiotics have emerged as a potential treatment modality for numerous gastrointestinal disorders, including IBD.
Giffard, P., Howarth, G., Giffard, Philip, Geier, M., Howarth, Gordon, Butler, R., Geier, Mark, Butler, Ross   +7 more
core   +1 more source

Selenomethionine Regulates the Arachidonic Acid Metabolism‐Ferroptosis‐Inflammation Axis to Ameliorate Colitis

Animal Research and One Health, EarlyView.
Selenomethionine can ameliorate arachidonic acid‐induced colonic injury through synergistic mechanisms, including alleviating inflammatory responses, improving barrier integrity, enhancing antioxidant capacity by upregulating selenoprotein expression, selectively regulating AA metabolism to reduce pro‐inflammatory oxylipins and promote the production ...
Huihui Tian, Longzhu Zhou, Xiaohui Feng, Jialu Shen, Xiaoping Du, Qingyu Zhao, Yuchang Qin, Junmin Zhang, Chaohua Tang   +8 more
wiley   +1 more source

Picking your brains: a DSS for neurosurgery

, 1995
This research involves the construction of a decision support system (DSS) to assist clinical managers in costing and contracting in the new internal market for neurosurgery in the UK National Health Service.
Lees, P., Powell, P., Connell, N.A.D., Sutcliffe, C.M.S.   +3 more
core  

EVALUASI EFEKTIFITAS PENILAIAN KINERJA APLIKASI DSS PADA KOPERASI SIMPAN PINJAM KELING KUMANG

, 2013
Credit union has a substantial role in supporting the growth of the national economy. A number of credit Unions implements DSS application to promote and accelerate the process of decision-making by management.
Juwita, Oktalia, Arief Dwi Hartadi, Oktalia Juwita, Dwi Hartadi, Arief   +3 more
core   +1 more source

Efficacy and Safety of Guselkumab in Participants With Active Psoriatic Arthritis After Inadequate Response to One Prior Tumor Necrosis Factor Inhibitor: Week‐24 Results of a Phase 3, Randomized, Placebo‐Controlled Study

Arthritis &Rheumatology, EarlyView.
Objective To evaluate the efficacy and safety of guselkumab, an interleukin‐23p19 subunit inhibitor, in participants with active psoriatic arthritis (PsA) and inadequate response (inadequate efficacy and/or intolerance) to one prior tumor necrosis factor (TNF) inhibitor.
Alexis Ogdie, Joseph F. Merola, Philip J. Mease, Christopher T. Ritchlin, Jose U. Scher, Kimberly Parnell Lafferty, Daphne Chan, Soumya D. Chakravarty, Wayne Langholff, Yanli Wang, Jie Shao, Yevgeniy Krol, Alice B. Gottlieb   +12 more
wiley   +1 more source

Combination Therapy in Participants With Active Psoriatic Arthritis Using Subcutaneous Guselkumab and Golimumab: Week 24 Results From a Phase 2a, Multicenter, Randomized, Double‐Blind, Proof‐of‐Concept Study

Arthritis &Rheumatology, EarlyView.
Objective To assess guselkumab + golimumab combination therapy versus guselkumab monotherapy in participants with active psoriatic arthritis (PsA) and inadequate response to tumor necrosis factor inhibitors (TNFi‐IR). Methods Adults with active TNFi‐IR PsA (three or more tender/swollen joints) were randomized (2:1) to subcutaneous guselkumab (100 mg) +
Jose U. Scher, Iain B. McInnes, Enrique R. Soriano, Joseph F. Merola, Paul Bird, Vinod Chandran, Edaire Cheng, Elena Reynoso, Warner Chen, Maoji Li, Lianne S. Gensler, Philip J. Mease, Christopher T. Ritchlin   +12 more
wiley   +1 more source

The use of decision support systems in making strategic decisions in local authorities : a comparative study of Egypt and the UK

The application of a modified Technology Acceptance Model (TAM) to determine the factors affecting the use of Decision Support Systems (DSS) in strategic decisionmaking in local authorities in both the UK and Egypt was the main core of this research ...
Elbeltagi, Ibrahim M.
core